Patents by Inventor Vincent Georges Christian Louis Verlant

Vincent Georges Christian Louis Verlant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds
    Patent number: 7521549
    Abstract: The invention provides BASB041, 43, 44 and 48 polypeptides and polynucleotides encoding BASB041, 43, 44 and 48 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Grant
    Filed: January 9, 2004
    Date of Patent: April 21, 2009
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Jean-Louis Ruelle, Vincent George Christian Louis Verlant
  • Novel compounds
    Publication number: 20040147474
    Abstract: The invention provides BASB041, 43, 44 and 48 polypeptides and polynucleotides encoding BASB041, 43, 44 and 48 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Application
    Filed: January 9, 2004
    Publication date: July 29, 2004
    Applicant: Smithkline Beecham Biologicals S.A.
    Inventors: Jean-Louis Ruelle, Vincent Georges Christian Louis Verlant
  • Vaccine composition
    Publication number: 20040131625
    Abstract: The present invention relates to the field of Gram-negative bacterial vaccine compositions, their manufacture, and the use of such compositions in medicine. More particularly it relates to the field of useful Gram-negative bacterial outer membrane vesicle (or bleb) compositions comprising heterologously expressed Chlamydia antigens, and advantageous methods of rendering these compositions more effective and safer as a vaccine.
    Type: Application
    Filed: February 3, 2004
    Publication date: July 8, 2004
    Inventors: Francois-Xavier Jacques Berthet, Yves Lobet, Jan Poolman, Vincent Georges Christian Louis Verlant
  • Compounds
    Patent number: 6706270
    Abstract: The invention provides BASB041, 43, 44 and 48 polypeptides and polynucleotides encoding BASB041, 43, 44 and 48 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Grant
    Filed: September 6, 2001
    Date of Patent: March 16, 2004
    Assignee: SmithKline Beecham Biologicals s.a.
    Inventors: Jean-Louis Ruelle, Vincent Georges Christian Louis Verlant
  • Vaccines
    Publication number: 20030219453
    Abstract: Vaccine preparations are provided for the prevention of Chylamydia infections comprising a major outer membrane protein from chlamydia and a mucosal adjuvant such as a combination of QS21 and 3D-MPL, or chlorea Toxin or Heat labile enterotoxin. Such preparations provide protection from Chlamydia induced fertility.
    Type: Application
    Filed: November 6, 2002
    Publication date: November 27, 2003
    Applicant: SmithKline Beecham Biologicals, sa
    Inventors: Jean-Francois Lucien Maisonneuve, Jean-Paul Prieels, Moncef-Mohamed Slaoui, Vincent Georges Christian Louis Verlant